Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population-based cohort
- PMID: 31621934
- DOI: 10.1111/apt.15511
Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population-based cohort
Abstract
Background: Lifetime risk of surgery in patients with Crohn's disease remains high.
Aim: To assess population-level markers of Crohn's disease (CD) in the era of biological therapy.
Methods: Population-based cohort study using administrative data from Ontario, Canada including 45 235 prevalent patients in the Ontario Crohn's and Colitis Cohort (OCCC) from 1 April 2003 to 31 March 2014.
Results: CD-related hospitalisations declined 32.4% from 2003 to 2014 from 154/1000 (95% confidence interval (CI) [150, 159]) patients to 104/1000 (95% CI [101, 107]) (P < .001). There was a 39.6% decline in in-patient surgeries from 53/1000 (95% CI [50, 55]) to 32/1000 (95% CI [30, 34]) from 2003 to 2014 (P < .001). In-patient surgeries were mostly bowel resections. Out-patient surgeries increased from 8/1000 (95% CI [7, 9]) patients to 12/1000 (95% CI [10, 13]) (P < .001). Out-patient surgeries were largely related to fistulas and perianal disease and for stricture dilations/stricturoplasty. CD-related emergency department (ED) visits declined 28.4% from 141/1000 (95% CI [137, 146]) cases to 101/1000 (95% CI [99, 104]) from 2003 to 2014 (P < .001). Over the same time, patients receiving government drug benefits received infliximab or adalimumab at a combined rate of 2.2% in 2003 which increased to 18.8% of eligible patients by 2014.
Conclusions: Rates of hospitalisations, ED visits and in-patient surgeries markedly declined in Ontario over the study period, while rates of biologic medication use increased markedly for those receiving public drug benefits.
© 2019 John Wiley & Sons Ltd.
Comment in
-
Editorial: better outcomes for Crohn's disease-more than just the drugs?Aliment Pharmacol Ther. 2020 Jan;51(1):167-168. doi: 10.1111/apt.15543. Aliment Pharmacol Ther. 2020. PMID: 31850570 No abstract available.
References
REFERENCES
-
- Rahman A, Williams P, Sandhu A, Mosli M. Malnutrition universal screening tool (MUST) scores predicts disease activity in patients with Crohn's disease. Can J Nutr. 2016;1:1-5.
-
- Sandhu A, Mosli M, Yan B, et al. Self-screening for malnutrition risk in outpatient inflammatory bowel disease patients using the malnutrition universal screening tool (MUST). J Parenter Enteral Nutr. 2016;40:507-510.
-
- Henriksen M, Jahnsen J, Lygren I, et al. Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study). Scand J Gastroenterol. 2007;42:602-610.
-
- Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785-1794.
-
- Peyrin-Biroulet L, Loftus E, Colombel J, Sandborn WJ. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol. 2010;105:289-297.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous